What are the momentum killers in clinical research and innovation?
In this episode, Ted Trafford discusses key issues that can kill site momentum on clinical trials and the adoption of innovation. He dives deep into the challenges that DCTs bring to sites, the flawed protocol feasibility model, and the barriers that sites and professionals face when entering the research industry. Ted believes in great potential for innovation but recognizes the industry too often forces solutions that are looking for problems that may not exist, creating unintended risk.
Listen to this episode where Ted Trafford reveals the secret to getting sites to pay attention to your trial.
Click this link to the show notes, transcript, and resources: outcomesrocket.health
Outcomes Rocket